MedPath

INVASC THERAPEUTICS, INC.

INVASC THERAPEUTICS, INC. logo
🇺🇸United States
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.invasc.net

Clinical Trials

4

Active:0
Completed:3

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 2
1 (25.0%)
Phase 4
1 (25.0%)

INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria

Phase 2
Completed
Conditions
Hypertension
Diabetes Mellitus, Type 2
Interventions
Drug: Active Control
First Posted Date
2011-07-20
Last Posted Date
2012-08-07
Lead Sponsor
InVasc Therapeutics, Inc.
Target Recruit Count
88
Registration Number
NCT01398423

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

Phase 4
Conditions
Hypertension
Interventions
First Posted Date
2011-01-06
Last Posted Date
2011-05-05
Lead Sponsor
InVasc Therapeutics, Inc.
Target Recruit Count
80
Registration Number
NCT01271374
Locations
🇺🇸

Atlanta Clinical Research Center, Tucker, Georgia, United States

Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension

Not Applicable
Completed
Conditions
Hypertension
Interventions
First Posted Date
2009-10-22
Last Posted Date
2011-05-05
Lead Sponsor
InVasc Therapeutics, Inc.
Target Recruit Count
40
Registration Number
NCT00999752
Locations
🇺🇸

Atlanta Vascular Research Foundation, Tucker, Georgia, United States

Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension

Not Applicable
Completed
Conditions
Diabetes
Hypertension
Interventions
Drug: accupril, placebo
Drug: accupril, alpha lipoic acid
First Posted Date
2008-11-21
Last Posted Date
2011-05-05
Lead Sponsor
InVasc Therapeutics, Inc.
Target Recruit Count
23
Registration Number
NCT00795262
Locations
🇺🇸

Atlanta Vascular Research Foundation, Tucker, Georgia, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.